Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cadonilimab, Radiotherapy, and Chemotherapy for Peritoneal Metastasis From Colorectal Cancer
NCT07815834Phase 3Recruiting
- Sponsor
- Fudan University
- Start
- Oct 2026
- Primary completion
- Aug 2030
- Countries
- 1
01
Overview
A Phase 3 trial of cadonilimab in colorectal cancer (CRC), sponsored by Fudan University. Started Oct 2026; status: recruiting.
02
Drugs
cadonilimab
03
Conditions
colorectal cancer (CRC)
Beyond the preview
Go deeper on NCT07815834.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07815834.